Alkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...

Adding to Ranbaxy's regulatory troubles overseas, certain drugs produced at its Dewas plant have been barred from export to all member coun...

The drug maker also plans to draw up detailed cross-selling plans for each state, according to industry consultants familiar with the matte...

Sun Pharmaceutical Industries said that it will buy generic drug maker Ranbaxy Laboratories, has hit regulatory snags in its key US market ...

Ranbaxy Laboratories has set aside Rs 257.4 crore towards the financial impact of a US ban on import of products made at its plant at Toans...

Days after US FDA banned import of Ranbaxy products to America from its Toansa plant, health regulators of EU & UK have said they are evalu...

"At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality".

UK has issued a statement clarifying that they have found no evidence that any of Ranbaxy’s products in the UK market “are or have been of ...

Apollo Pharmacy today said it has resolved the matter and will continue to sell Ranbaxy's medicines from its outlets across the country.

DGCI is confident of the quality standards of Indian medicines despite concerns raised by US authorities over some of Ranbaxy's products

Ranbaxy has assured the public that drugs manufactured locally are safe days after the Indian firm paid a fine of $500 million in the US.

Ranbaxy today claimed that its "products currently in the Indian market and globally are safe and efficacious".

Beleaguered drug maker Ranbaxy claimed its "products currently in the Indian market and globally are safe and efficacious".

Daiichi Sankyo & Ranbaxy announced that Daiichi Sankyo Venezuela would begin marketing Ranbaxy products in Venezuela as part of hybrid busi...

Ranbaxy’s Japanese parent Daiichi Sankyo has set up a new firm, Daiichi Sankyo Espha Company (DSECL) for marketing generic drugs in Japan.

Ranbaxy Laboratories has received regulatory nod for its Poanta Sahib plant in Himachal Pradesh from European and Australian drug regulator...

FDA move does not end US sales by Ranbaxy. The factories with defects are in Dewas and Paonta Sahib. The Top 10 food myths revealed | Bewar...